Series dedicated to the Congress on Clinical Controversies in Lung Cancer (CCLC 2018)

Posted On 2020-09-02 10:20:04


The series dedicated to the Congress on Clinical Controversies in Lung Cancer (CCLC 2018) was edited by Prof. Nir Peled, Oncology Division, the Legacy Heritage Oncology Center & Larry Norton Institute, Soroka Medical Center, Ben-Gurion University, Beer-Sheva, Israel.

This series is a joint effort between the congress and the journal to widely expose the meeting contents for greater impact and make them most readily available by clinicians and researchers all around the world.

Editorial
The current and future revolution in lung cancer screening and management
Waleed Kian, Nadav Wallach, Nir Peled

Review Article
Prophylactic cranial irradiation (PCI) or magnetic resonance imaging (MRI) monitoring in limited small cell lung cancer: is it a question?
Paul Van Houtte, Martine Roelandts, Florian Charlier, Luigi Moretti, Dirk Van Gestel

Disease progression in non-small cell lung cancer on immune-checkpoint inhibition, what are the options?
Rudolf M. Huber

ALK disease: best first or later, and do we care about variants?
Petros Christopoulos

Low-dose lung cancer screening: nodule measurement and management
Joan E. Walter, Marjolein A. Heuvelmans, Monique Dorrius, Matthijs Oudkerk

Annotating the next generation sequencing report
Miguel A. Molina-Vila, Clara Mayo-de-las-Casas, Mónica Garzón-Ibáñez, Núria Jordana-Ariza, Beatriz García-Peláez, Ariadna Balada-Bel, Rafael Rosell

Non-small cell lung cancer PDL1 >50%—should we go single or combo?
Waleed Kian, Laila C. Roisman, Dina Levitas, Nadav Wallach, Adam Abo-Sharb, Aharon Y. Cohen, Alexander Yakobson, Nir Peled, Yulia Dudnik


Disclosure:
The series dedicated to the Congress on Clinical Controversies in Lung Cancer (CCLC 2018) was commissioned by the editorial office, Precision Cancer Medicine without any sponsorship or funding. Nir Peled served as the unpaid Guest Editor for the series.